The Multifarious Link between Cytochrome P450s and Cancer

Abdullah M Alzahrani1, Peramaiyan Rajendran1

  • 1Department of Biological Sciences, College of Science, King Faisal University, Hofouf, 31982, Saudi Arabia.

Insights

Cytochrome P450s (P450s) are crucial enzymes involved in drug metabolism. This review highlights their significant role in cancer development, prevention, and metastasis, offering insights into molecular mechanisms.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Cancer is a major global health concern.
  • Cytochrome P450s (P450s) are key enzymes in metabolizing endogenous and exogenous compounds, including drugs.
  • P450s are increasingly recognized for their dual role in cancer, acting as both contributors and therapeutic targets.

Purpose of the Study:

  • To elucidate the current understanding of cancer's molecular mechanisms involving P450 enzymes.
  • To consolidate research linking P450 enzyme activity to cancer formation, prevention, and metastasis.

Main Methods:

  • Comprehensive literature review of epidemiological, diagnostic, and clinical studies.
  • Analysis of molecular mechanisms underlying P450 involvement in carcinogenesis.
  • Synthesis of data on P450s in cancer progression and therapeutic strategies.

Main Results:

  • P450 enzymes significantly influence the initiation, progression, and spread of cancer.
  • Specific P450 isoforms are implicated in the metabolic activation or detoxification of carcinogens.
  • P450s present potential targets for novel cancer therapies and diagnostics.

Conclusions:

  • P450 enzymes are integral to cancer biology, affecting multiple stages of the disease.
  • Understanding P450-cancer interactions is vital for developing effective cancer prevention and treatment strategies.
  • Further research into P450 modulation holds promise for oncology.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K